Cargando…

Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report

Detalles Bibliográficos
Autores principales:	Rivera-Esteban, Jesús, Barberá, Aurora, Salcedo, Maria Teresa, Martell, Maria, Genescà, Joan, Pericàs, Juan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720430/ https://www.ncbi.nlm.nih.gov/pubmed/36478872 http://dx.doi.org/10.1016/j.jhepr.2022.100618

Ejemplares similares

A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo
por: Pinheiro, Iris, et al.
Publicado: (2022)

Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH
por: Bravo, Miren, et al.
Publicado: (2019)

Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD
por: Pons, Mònica, et al.
Publicado: (2022)

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study
por: Bañares, Juan, et al.
Publicado: (2022)

Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
por: Ezkurdia, Nahia, et al.
Publicado: (2014)

Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases
por: Gil, Mar, et al.
Publicado: (2023)

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH
por: Bravo, Miren, et al.
Publicado: (2021)

Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study
por: Pirhonen, Juho, et al.
Publicado: (2016)

Patient-reported outcomes in NAFLD/NASH clinical trials: A blind spot that needs addressing
por: Sena, Elena, et al.
Publicado: (2022)

A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
por: Rodríguez, Sarai, et al.
Publicado: (2017)

Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD
por: Di Mauro, Stefania, et al.
Publicado: (2021)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender
por: Porcu, Cristiana, et al.
Publicado: (2018)

When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD
por: Rojano-Toimil, Alba, et al.
Publicado: (2022)

TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
por: Wandrer, Franziska, et al.
Publicado: (2020)

Reduced hepatocyte mitophagy is an early feature of NAFLD pathogenesis and hastens the onset of steatosis, inflammation and fibrosis
por: Undamatla, Ramya, et al.
Publicado: (2023)

Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study
por: Amanatidou, Athina I., et al.
Publicado: (2023)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis
por: Undamatla, R., et al.
Publicado: (2023)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
por: Rivera-Esteban, Jesús, et al.
Publicado: (2022)

What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review
por: Talens, Mar, et al.
Publicado: (2021)

Prognostic Evaluation of Patients with Acute Variceal Bleeding
por: Augustin, Salvador, et al.
Publicado: (2011)

Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
por: Peleg, Noam, et al.
Publicado: (2019)

Uncovering the NAFLD burden in people living with HIV from high‐ and middle‐income nations: a meta‐analysis with a data gap from Subsaharan Africa
por: Manzano‐Nunez, Ramiro, et al.
Publicado: (2023)

Non-invasive real-time assessment of hepatic macrovesicular steatosis in liver donors: Hypothesis, design and proof-of-concept study
por: Rajamani, Allwyn S, et al.
Publicado: (2021)

Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD
por: Sapmaz, Ferdane, et al.
Publicado: (2016)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
por: Kosasih, Sumitro, et al.
Publicado: (2018)

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
por: Kamp, Jan C., et al.
Publicado: (2021)

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
por: Seo, Jung Wook, et al.
Publicado: (2023)

Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study
por: Muley, Moises, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ei98p2nbjk2ei3g4adqn9umdof